Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-1,3/1,6-D-Glucan in Ulcerative Colitis
NCT04029649Phase 3Unknown
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Polysaccharide, Dietary Supplement
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ulcerative colitis (UC) comparing Beta-1,3/1,6-D-Glucan with Placebo (2 arms). Primary endpoint: Short Form-36 Health Survey at 90 days. Status: unknown.
02
Drugs
beta-1,3/1,6-d-glucan
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04029649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04029649.